Population
Healthy young subjects in first-entry-into-man (FIM) studies
Authors
Loading...
May standardize safety assessments in first-in-human trials; extends points to consider for dose-escalation protocols.
A proposed safety grading scale provides 'points to consider' for rationalizing dose escalation and stopping rules in first-in-human trials.
Sibille et al. (2010) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: